Haemonetics Corp
Haemonetics Corporation (HAE) supplies blood- and plasma-management systems, disposables and software to hospitals, blood centres and plasma collectors worldwide. Investors should know the business mixes recurring revenue from consumables with equipment sales and service contracts, which can provide revenue visibility but is sensitive to procedure volumes and reimbursement. The company competes on product innovation, supply reliability and regulatory compliance; acquisitions and new product roll-outs can support growth but also carry execution risk. Key risks include regulatory change, reimbursement pressure, cyclic healthcare spending and competition from larger medical-device companies. With a market capitalisation around $2.47bn, HAE can appeal to those seeking exposure to specialised medical devices, though it may be more volatile than large-cap healthcare names. This is general educational information, not personal advice — values can rise and fall and returns are not guaranteed. Consult your financial adviser to assess whether this stock fits your objectives and risk tolerance.
Stock Performance Snapshot
Analyst Rating
Analysts suggest buying Haemonetics' stock with a target price of $91.70, indicating strong growth potential.
Financial Health
Haemonetics is showing strong revenue and cash flow, with healthy profit margins supporting its growth.
Dividend
Haemonetics Corp's projected dividend yield of 1% is below average, indicating limited returns for dividend-seeking investors. If you invested $1000 you would be paid $10 a year in dividends (based on the last 12 months).
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring HAE
The Plasma Profit Pipeline
Biopharmaceutical leader CSL reported a 14% surge in annual profit, fueled by its plasma division's success. This highlights a growing investment opportunity in companies involved in the plasma-derived therapies market and the broader bioprocessing supply chain.
Published: August 19, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Recurring Revenue Mix
Consumables and service contracts provide steady revenue streams, offering predictability, though performance can vary with procedure volumes and reimbursement.
Product Innovation Focus
New devices and software can drive market share and margins, but R&D, regulatory approval and execution risk can affect outcomes.
Global Market Exposure
A presence across hospitals and blood centres gives geographic diversification, yet differing regulations and healthcare budgets can create varied performance.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Agilent Technologies Inc.
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. The Life Sciences and Diagnostics Markets segment provides contract development and manufacturing services for pharmaceutical customers as well as solutions that include reagents, instruments, software and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab segment spans the entire lab with its services and consumables portfolio in addition to software and laboratory automation solutions, which are designed to improve customer outcomes and represent a range of offerings designed to serve customer needs across end-markets and applications.
Align Technology Inc.
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
